Jay W. Pettegrew

Best Publications

• Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

  Jay W. Pettegrew;Matcheri S. Keshavan;Kanagasabai Panchalingam;Sandra Strychor

  690
  Citations

• Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

  Matcheri S. Keshavan;Stewart A. Anderson;Jay W. Pettegrew

  676
  Citations

• Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

  J W Pettegrew;J Levine;J Levine;R J McClure

  397
  Citations

• Brain membrane phospholipid alterations in Alzheimer's disease.

  Jay W. Pettegrew;Kanagasabai Panchalingam;Ronald L. Hamilton;Richard J. McClure

  370
  Citations

• Changes in caudate volume with neuroleptic treatment.

  MatcheriS. Keshavan;WernerW. Bagwell;GretchenL. Haas;JohnA. Sweeney

  330
  Citations

• Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease.

  William E. Klunk;Manik L. Debnath;Jay W. Pettegrew

  297
  Citations

• Increased cerebrospinal fluid glutamine levels in depressed patients.

  Joseph Levine;Joseph Levine;Kanagasabai Panchalingam;Avraham Rapoport;Samuel Gershon

  288
  Citations

• Decreased Caudate Volume in Neuroleptic-Naive Psychotic Patients

  Matcheri S. Keshavan;David Rosenberg;John A. Sweeney;Jay W. Pettegrew

  282
  Citations

• Superior temporal gyrus and the course of early schizophrenia : progressive, static, or reversible?

  Matcheri S Keshavan;Gretchen L Haas;Charles E Kahn;Eduardo Aguilar

  278
  Citations

• A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease

  L. J. Thal;A. Carta;W. R. Clarke;S. H. Ferris

  265
  Citations

• Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study

  Jay W. Pettegrew;Kanagasabai Panchalingam;William E. Klunk;Richard J. McClure

  263
  Citations

• Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body Disease

  Pravat K. Mandal;Jay W. Pettegrew;Eliezer Masliah;Ronald L. Hamilton

  257
  Citations

• N‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study

  W. E. Klunk;K. Panchalingam;J. Moossy;R. J. McClure

  247
  Citations

• A preliminary 31P MRS study of autism: Evidence for undersynthesis and increased degradation of brain membranes

  Nancy J. Minshew;Gerald Goldstein;Stephen M. Dombrowski;Kanagasabai Panchalingam

  245
  Citations

• Development of the corpus callosum in childhood, adolescence and early adulthood.

  Matcheri S Keshavan;Vaibhav A Diwadkar;Michael DeBellis;Elizabeth Dick

  225
  Citations

• Diagnostic Specificity and Neuroanatomical Validity of Neurological Abnormalities in First-Episode Psychoses

  Matcheri S. Keshavan;Richard D. Sanders;John A. Sweeney;Vaibhav A. Diwadkar

  221
  Citations

• 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations.

  J. W. Pettegrew;S. J. Kopp;S. J. Kopp;N. J. Minshew;T. Glonek;T. Glonek

  221
  Citations

• Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

  Jay W. Pettegrew;William E. Klunk;Kanagasabai Panchalingam;Julian N. Kanfer

  217
  Citations

• 31P nuclear magnetic resonance study of the brain in Alzheimer's disease.

  Jay W. Pettegrew;John Moossy;Gayathri Withers;Dennis McKeag

  208
  Citations

• Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe

  William E. Klunk;Manik L. Debnath;Jay W. Pettegrew

  205
  Citations